SIMPONI ARIA (golimumab)


Drug overview for SIMPONI ARIA (golimumab):

Generic name: GOLIMUMAB (goe-LIM-ue-mab)
Drug class: Inflammatory Bowel Agents
Therapeutic class: Analgesic, Anti-inflammatory or Antipyretic

Golimumab, a human immunoglobulin G1 kappa (IgG1) monoclonal antibody, is a tumor necrosis factor (TNF) inhibitor that is a biologic disease-modifying antirheumatic drug (DMARD).

No enhanced Uses information available for this drug.
DRUG IMAGES
  • SIMPONI ARIA 50 MG/4 ML VIAL
    SIMPONI ARIA 50 MG/4 ML VIAL
The following indications for SIMPONI ARIA (golimumab) have been approved by the FDA:

Indications:
Ankylosing spondylitis
Polyarticular juvenile idiopathic arthritis
Psoriatic arthritis
Rheumatoid arthritis


Professional Synonyms:
Arthritis deformans
Arthrosis deformans
Axial spondyloarthritis with radiographic sacroiliitis
Bekhterev's arthritis
Bekhterev's disease
Bekhterev's spondylitis
Marie-Strumpell disease
Marie-Strumpell spondylitis
Nodose rheumatism
Polyarticular JIA
Polyarticular JRA
Polyarticular juvenile chronic arthritis
Polyarticular juvenile rheumatoid arthritis
Psoriasis arthropica
Psoriatic arthropathy
Rheumatic arthritis
Rheumatic gout
Rheumatoid spondylitis
Rhizomelic spondylitis
Rhizomelic spondylosis
Spondylosis deformans
Strumpell-Marie disease